Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs

dc.contributor.author	Doğan, A.
dc.contributor.author	Özdemir, E.
dc.contributor.author	Kahraman, S.
dc.contributor.author	Açıl, T.
dc.contributor.author	Saltan, Y.
dc.contributor.author	Kurtoğlu, N.
dc.date.accessioned	2021-12-21T08:41:11Z
dc.date.available	2021-12-21T08:41:11Z
dc.date.issued	2017
dc.identifier.issn	21492263
dc.identifier.uri	https://doi.org/10.14744/AnatolJCardiol.2017.7885
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1349
dc.description.abstract	Objective: Early cessation of dual antiplatelet therapy (DAPT) is related to stent thrombosis (ST). The use of second-generation everolimus- and zotarolimus-eluting stents is associated with low restenosis rates and short duration of clopidogrel usage. No
dc.language.iso	English
dc.publisher	Turkish Society of Cardiology
dc.rights	All Open Access, Gold, Green
dc.title	Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs
dc.type	Article
dc.relation.journal	Anatolian Journal of Cardiology
dc.identifier.issue	6
dc.identifier.startpage	391
dc.identifier.endpage	396
dc.identifier.volume	18
dc.identifier.doi	10.14744/AnatolJCardiol.2017.7885
dc.relation.issue	6
dc.relation.volume	18